Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 24.3% in October

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 2,970,000 shares, an increase of 24.3% from the September 30th total of 2,390,000 shares. Approximately 8.7% of the shares of the company are short sold. […]

Related Keywords

Piper Sandler ,Kennedy Capital Management ,Diamond Therapeutics Inc ,Nasdaq ,Diamond Therapeutics Company Profile ,Boothbay Fund Management ,Black Diamond Therapeutics ,Get Free Report ,Diamond Therapeutics Trading Down ,Diamond Therapeutics ,Capital Management ,Black Diamond Therapeutics Daily ,Nasdaq Bdtx ,Bdtx ,Medical ,Stocks ,Options ,Put ,Call ,